Emily C Pickering1,2, Bec Hanley3, Philip Bell3, Jacqui Gath3, Patrick Hanlon3, Robert Oldroyd3, Richard Stephens4, Conor D Tweed3. 1. AGE Research Unit, Imperial College London, London, UK. emily.pickering@nihr.ac.uk. 2. Institute of Clinical Trials and Methodology, University College London, London, UK. emily.pickering@nihr.ac.uk. 3. Medical Research Council Clinical Trials Unit at University College London, London, UK. 4. NCRI Consumer Liaison Group, London, UK.
Abstract
BACKGROUND: Clinical Trials Units are encouraged to integrate Patient and Public Involvement (PPI) into all aspects of trial design, running and oversight. This research explored the induction and training of PPI Contributors joining trial oversight committees and was used to update the Medical Research Council Clinical Trials Unit at University College London's (MRC CTU at UCL) induction pack for new PPI Contributors. METHODS: Published and unpublished materials provided by other CTUs and research organisations on training for PPI Contributors on oversight committees were reviewed, with themes then triangulated to identify the most common topics covered in induction training. A face-to-face workshop with PPI Contributors from the MRC CTU at UCL reviewed a draft updated Induction Pack. Findings from these discussions were incorporated into a revised induction pack which was then re-reviewed by the workshop attendees. RESULTS: No published literature on this subject was found. However, several common themes were identified from unpublished materials. Workshop attendees agreed with most of the themes suggested in the initial draft pack based on the literature search and also provided a number of additional topics for discussion. CONCLUSIONS: There is very little consistency in the induction of PPI Contributors on oversight committees. Whilst most local guidance explains the general role of a PPI Contributor, more context and background of the particular trial needs to be provided to allow for adequate induction of new committee members. The Induction Pack created provides a framework upon which trial managers can build a full picture of their study.
BACKGROUND: Clinical Trials Units are encouraged to integrate Patient and Public Involvement (PPI) into all aspects of trial design, running and oversight. This research explored the induction and training of PPI Contributors joining trial oversight committees and was used to update the Medical Research Council Clinical Trials Unit at University College London's (MRC CTU at UCL) induction pack for new PPI Contributors. METHODS: Published and unpublished materials provided by other CTUs and research organisations on training for PPI Contributors on oversight committees were reviewed, with themes then triangulated to identify the most common topics covered in induction training. A face-to-face workshop with PPI Contributors from the MRC CTU at UCL reviewed a draft updated Induction Pack. Findings from these discussions were incorporated into a revised induction pack which was then re-reviewed by the workshop attendees. RESULTS: No published literature on this subject was found. However, several common themes were identified from unpublished materials. Workshop attendees agreed with most of the themes suggested in the initial draft pack based on the literature search and also provided a number of additional topics for discussion. CONCLUSIONS: There is very little consistency in the induction of PPI Contributors on oversight committees. Whilst most local guidance explains the general role of a PPI Contributor, more context and background of the particular trial needs to be provided to allow for adequate induction of new committee members. The Induction Pack created provides a framework upon which trial managers can build a full picture of their study.
Entities:
Keywords:
Clinical trials; Independent data monitoring committee; Induction; Oversight committee; Patient and Public Involvement; Trial management group; Trial steering committee
Authors: Femke M A P Claessen; Jos J Mellema; Nicky Stoop; Bart Lubberts; David Ring; Rudolf W Poolman Journal: Psychosomatics Date: 2015-10-01 Impact factor: 2.386
Authors: Elizabeth J Conroy; Nicola L Harman; J Athene Lane; Steff C Lewis; Gordon Murray; John Norrie; Matt R Sydes; Carrol Gamble Journal: Clin Trials Date: 2015-06-17 Impact factor: 2.486
Authors: Heather J Bagley; Paula R Williamson; Hannah Short; Nicola L Harman; Helen R Hickey; Carrol L Gamble; Kerry Woolfall; Bridget Young Journal: Res Involv Engagem Date: 2016-04-27
Authors: Anna Kearney; Paula Williamson; Bridget Young; Heather Bagley; Carrol Gamble; Simon Denegri; Delia Muir; Natalie A Simon; Stephen Thomas; Jim T Elliot; Helen Bulbeck; Joanna C Crocker; Claire Planner; Claire Vale; Mike Clarke; Tim Sprosen; Kerry Woolfall Journal: Health Expect Date: 2017-06-15 Impact factor: 3.377
Authors: Anne McKenzie; Janelle Bowden; John R Zalcberg; Karena Conroy; Julia Fallon-Ferguson; Shilpanjali Jesudason; James Ansell; Ania Anderst; Nicola Straiton Journal: Res Involv Engagem Date: 2022-02-05